Giant Axonal Neuropathy (GAN) Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Giant Axonal Neuropathy (GAN) Market is segmented By Treatment (Gene Therapy, Enzyme Replacement The...

Giant Axonal Neuropathy (GAN) Market Size

Market Size in USD Mn

CAGR5.7%

Study Period2025-2032
Base Year of Estimation2024
CAGR5.7%
Market ConcentrationHigh
Major PlayersApplied Genetic Technologies Corporation (AGTC), Audentes Therapeutics (acquired by Astellas Pharma), Passage Bio, Voyager Therapeutics, Neuron Biopharma and Among Others
*Disclaimer: Major players are listed in no particular order.
*Source: Coherent Market Insights
setting-icon
Want to purchase customized report?
please let us know !

Giant Axonal Neuropathy (GAN) Market Analysis

The giant axonal neuropathy (GAN) Market is estimated to be valued at USD 126.4 Mn in 2025 and is expected to reach USD 186.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2032. Enhanced research activities for development of novel treatment therapies have boosted growth prospects for the giant axonal neuropathy (GAN) market.

Giant Axonal Neuropathy (GAN) Market Report Snapshots

Giant Axonal Neuropathy (GAN) Market Size